Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
|Articles|October 2, 2019
- Pharmaceutical Technology-10-02-2019
- Volume 43
- Issue 10
Pharmaceutical Cleanroom Monitoring
Airnet II Stainless Steel by Particle Measuring Systems (PMS) aids in cleanroom monitoring in high dust and moisture environments.
Airnet II Stainless Steel by Particle Measuring Systems (PMS) aids in cleanroom monitoring in high dust and moisture environments. The device is built on an Airnet II 501/510XR platform, which provides a small footprint, reliable performance, and data transmission capabilities while meeting ISO 21501-4 specifications.
Made with a 316L stainless steel exterior, the new product was tested by a third-party laboratory to CEI/IEC60529 standards to withstand harsh dust environments and liquid environments equivalent to direct contact from a waterjet, eliminating the risk of damage from cleanroom environmental and cleaning processes.
The device can be added to existing PMS monitoring systems or upgraded with FacilityPro software to provide continuous monitoring while cleaning procedures stay intact.
Articles in this issue
almost 7 years ago
FT-IR Spectrometeralmost 7 years ago
Nexera Prep Seriesalmost 7 years ago
Multi-Shaft Mixers for High-Quality Gels and Creamsalmost 7 years ago
Stability Testing for Small-Molecule Clinical Trial Materialsalmost 7 years ago
Image Repair Must Get to the Root Causealmost 7 years ago
The Never-Ending Brexit?almost 7 years ago
Out with the Old and In with the New European Commissionalmost 7 years ago
Data Integrity Violations Draw Strong FDA Rebukesalmost 7 years ago
The Fundamentals of Dissolution Testingalmost 7 years ago
Overcoming Bioavailability ‘Roadblocks’ with LBDDSRelated to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Trending on Pharmaceutical Technology
1
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
2
PharmTech AI Pulse Check: Validating Multi-Agent Systems, OCR Models in GxP
3
CPHI Milan: USP Benchmarks Reshape Procurement Incentives
4
Pharma Fundamentals: Digital Pathology in Drug Development, Part 1
5